GV (nerve agent): Difference between revisions
Appearance
Content deleted Content added
Corrections to IUPAC name in the beginning |
formating |
||
Line 6: | Line 6: | ||
| ImageFile1 = |
| ImageFile1 = |
||
| ImageName1 = Ball-and-stick model of GV |
| ImageName1 = Ball-and-stick model of GV |
||
| IUPACName = 2-(Dimethylamino)ethyl N,N-dimethylphosphoroamidofluoridate |
| IUPACName = 2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoroamidofluoridate |
||
| Section1 = {{Chembox Identifiers |
| Section1 = {{Chembox Identifiers |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
Line 30: | Line 30: | ||
}} |
}} |
||
'''GV''' ([[IUPAC]] name: 2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate) is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent [[acetylcholinesterase]] inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as [[atropine]], [[benactyzine]], [[obidoxime]] and [[HI-6]].<ref>Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. ''Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove''. 1994;37(2):57-62. PMID 7784799</ref><ref>Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. ''Acta Medica (Hradec Kralove)''. 1996;39(1):27-30. PMID 9106387</ref> |
'''GV''' ([[IUPAC]] name: '''2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate''') is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent [[acetylcholinesterase]] inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as [[atropine]], [[benactyzine]], [[obidoxime]] and [[HI-6]].<ref>Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. ''Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove''. 1994;37(2):57-62. PMID 7784799</ref><ref>Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. ''Acta Medica (Hradec Kralove)''. 1996;39(1):27-30. PMID 9106387</ref> |
||
==References== |
==References== |
Revision as of 20:32, 19 February 2011
Names | |
---|---|
IUPAC name
2-(Dimethylamino)ethyl N,N-dimethylphosphoroamidofluoridate
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H16FN2O2P | |
Molar mass | 198.176 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
GV (IUPAC name: 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate) is an organophosphate nerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime and HI-6.[1][2]
References
- ^ Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove. 1994;37(2):57-62. PMID 7784799
- ^ Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. Acta Medica (Hradec Kralove). 1996;39(1):27-30. PMID 9106387
See also
External links
Wikimedia Commons has media related to GV nerve agent.